BridgeBio Pharma Inc (BBIO)

BridgeBio Pharma (BBIO) Financial Statements


BridgeBio Pharma Financial Overview

BridgeBio Pharma's market cap is currently ―. The company's EPS TTM is $-3.228; its P/E ratio is -8.48; BridgeBio Pharma is scheduled to report earnings on August 1, 2024, and the estimated EPS forecast is $-1.00. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 1.75M$ 4.09M$ 1.64M$ 1.83M$ 1.87M
Gross Profit$ 496.00K$ 3.49M$ 1.64M$ 1.18M$ 1.22M
EBIT$ -150.06M$ -151.54M$ -132.47M$ -130.25M$ -120.58M
EBITDA$ -148.47M-$ -130.83M$ -128.62M$ -118.92M
Net Income Common Stockholders$ -168.15M$ -177.00M$ -157.90M$ -140.16M$ -137.59M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 434.88M$ 543.26M$ 403.72M$ 516.80M$ 471.92M
Total Assets$ 546.38M$ 655.01M$ 503.66M$ 625.68M$ 623.04M
Total Debt$ 459.55M$ 455.67M$ 455.19M$ 451.34M$ 1.72B
Net Debt$ 24.67M$ -87.59M$ 51.46M$ -65.45M$ 1.25B
Total Liabilities$ 1.89B$ 1.85B$ 1.85B$ 1.84B$ 1.87B
Stockholders Equity$ -1.35B$ -1.21B$ -1.36B$ -1.23B$ -1.25B
Cash Flow-
Free Cash Flow$ -125.25M-$ -113.78M$ -144.33M$ -94.04M
Operating Cash Flow$ -124.82M$ -145.23M$ -113.35M$ -144.32M$ -93.24M
Investing Cash Flow$ -66.00K$ 37.68M$ 4.12M$ 12.30M$ 17.96M
Financing Cash Flow$ -4.52M$ 307.04M$ -1.23M$ 150.25M$ 6.38M
Currency in USD

BridgeBio Pharma Earnings and Revenue History

BridgeBio Pharma Debt to Assets

BridgeBio Pharma Cash Flow

BridgeBio Pharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis